Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 809 results for "avp research"

Buy Poly Medicure, says Sandeep Raina

Sandeep Raina, AVP at Edelweiss RCM Research recommends buying Poly Medicure with a view of more than one and half years. Money Control, 6 days ago
V-Mart Retail good buy, says Sandeep Raina Money Control, 6 days ago
Here are Sandeep Raina's top trading ideas Money Control, 6 days ago

6 images for avp research

Starmometer, 2 days ago
Mideast Time, 1 week ago
American Banking News, 1 week ago
Mideast Time, 3 weeks ago
American Banking News, 3 weeks ago
Silicon India, 1 month ago

Buy silver natural gas; sell zinc: Navneet Damani

Watch the interview of Navneet Damani, AVP Commodities Currency Research at Motilal Oswal Commodities with Ekta Batra and Reema Tendulkar on CNBC-TV18. He spoke about the current trend in commodities markets.
 Money Control3 weeks ago

Hindalco underperformance due to interest cost rise: IIFL

Reacting to the Hindalco numbers, Tarang Bhanushali, AVP- Research, IIFL says the underperformance is largely due to a jump in interest cost which has come due to commissioning of new capacities during the quarter.
 Money Control1 month ago

Avon Products Rating Increased to Buy at BTIG Research (AVP)

Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a neutral rating on shares of Avon Products in a research note on Wednesday, August 27th. They now have a $15.00 price target on the stock. Separately, ...
 American Banking News1 week ago Avon Products's Neutral Rating Reiterated at Zacks (AVP)  American Banking News3 weeks ago Avon Products (AVP) Continues Dismal Earnings Trend in Q2  Yahoo! Finance1 month ago

Avon Products Price Target Cut to $15.00 by Analysts at Citigroup Inc. (AVP)

Research analysts at Citigroup Inc. dropped their price objective on shares of Avon Products (NYSE:AVP) AVP has been the subject of a number of other recent research reports. Analysts at BTIG Research upgraded shares of Avon Products from a ...
 American Banking News1 week ago Avon Products Downgraded by Citigroup Inc. (AVP)  American Banking News2 days ago Avon Products Cut to Neutral at Citigroup Inc. (AVP)  Mideast Time1 week ago Short Interest in Avon Products Rises By 40.4% (AVP)  American Banking News1 month ago
American Banking News

Research Analysts Upgrades for September, 9th (AVP, BKNIY, DEO, FBC, FNV, KLKNF, MRO, TOT, TRGP, UL)

Research Analysts upgrades for Tuesday, September 9th: KLOECKNER & CO
 American Banking News1 week ago
American Banking News

Research Analysts Ratings Reiterations for August, 27th (ABM, ADI, AEE, AGU, AVP, C, CBSH, COO, CZZ, DF)

Research Analysts ratings reiterations for Wednesday, August 27th: ABM Industries (NYSE:ABM) Analog Devices (NYSE:ADI) Ameren Corp (NYSE:AEE) Agrium (NYSE:AGU) Avon Products (NYSE:AVP) Citigroup (NYSE:C) Commerce Bancshares ...
 American Banking News3 weeks ago

All Pop And No Sizzle Or Is Avanir Going Higher From Here?

Summary AVNR has rose 271% YTD and sits 377% above the 52 week low. Any foreseeable upside on AVP-923 has been completely baked in, and then some. AVP-923 may not be a novel enough formula to get approval or exclusivity. It can be a pretty ...
 Seeking Alpha4 days ago

Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data

Shares of Avanir Pharmaceuticals ( AVNR ) gained a massive 85.31% to close the trading session on Sep 15 at $12.49. The jump came on the back of encouraging data from a phase II study (n=220) on Avanirs AVP-923, which evaluated the safety, ...
 Yahoo! Finance4 days ago Avanir's shares jump on positive mid-stage data for AVP-923 in Alzheimer's disease agitation  FirstWord Pharma5 days ago
Pharma Letter

Avanir shares jump 85% on positive AVP-923 clinical trial results

US CNS specialist Avanir Pharmaceuticals (Nasdaq: AVNR) has announced positive results from the Phase II clinical trial of its experimental therapy AVP-923 (dextromethorphan/quinidine), prompting its share price to leap 85%. to $12.49 in post-market ...
 Pharma Letter5 days ago Alzheimer's Study Results Take Avanir Back Up to Multiyear Highs  24/7 Wall St5 days ago Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation …  Yahoo! Finance6 days ago Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for Major Depressive Disorder  Drugs.com1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less